| Financial Year |
March 31 2023 |
| Monetary Funds |
321,963,005.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
20,852,670.60 |
| Accounts Receivable |
1,063,847,199.01 |
| Advances to Suppliers |
65,593,671.39 |
| Other Receivables |
14,064,037.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
241,202,629.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
383,232,364.89 |
| Other Current Assets |
911,627.53 |
| Total Current Assets |
2,111,667,206.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,677,585.25 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
354,982,166.33 |
| Under-construction Projects |
106,944,633.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
63,764,952.89 |
| R&D expenses |
-- |
| Goodwill |
1,672,545,682.47 |
| Long-Term Deferred and Prepaid Expenses |
3,105,040.14 |
| Deferred Income Tax Assets |
37,718,666.63 |
| Other Non-Current Assets |
295,422,687.32 |
| Sub-Total of Non-Current Assets |
2,575,355,956.64 |
| Total Assets |
4,687,023,163.00 |
| Short-Term Loans |
59,703,565.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,414,670.00 |
| Accounts Payable |
45,172,388.81 |
| Accounts Received In Advance |
968,388.87 |
| Employee Compensation Payable |
13,925,933.41 |
| Taxes Payable |
36,744,120.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,861,346.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,487,773.45 |
| Other Current Liabilities |
6,409,607.02 |
| Sub-Total of Current Liabilities |
232,195,684.26 |
| Long-term Loans |
71,836,494.82 |
| Bonds Payable |
977,498,453.29 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,357,032.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,077,709,097.17 |
| Total Liabilities |
1,309,904,781.43 |
| Paid-In Capital(Or Share Stock) |
588,846,703.00 |
| Capital Surplus |
391,516,849.42 |
| Surplus Reserve |
249,622,267.77 |
| LESS:Treasury Stock |
93,072,437.13 |
| Undistributed Profits |
2,064,756,242.60 |
| Minority Stockholder's Interest |
-4,332,106.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,381,450,488.45 |
| Owner's Equity（Stockholder's Equity） |
3,377,118,381.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,687,023,163.00 |
